ribavirin has been researched along with Koch's Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahmer, BR; Ethur, EM; Timmers, LFSM | 1 |
| Wahid, B | 1 |
| Chen, TC; Chen, YH; Lin, CY; Lin, SY; Lin, WR; Lu, PL; Yang, YH | 1 |
| Anselmo, M; De Leo, P; Grasso, A; Malfatti, F; Menardo, G; Toscanini, F | 1 |
4 other study(ies) available for ribavirin and Koch's Disease
| Article | Year |
|---|---|
Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase - A computational study.
Topics: 3-Phosphoshikimate 1-Carboxyvinyltransferase; Antitubercular Agents; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Ribavirin; Tuberculosis | 2023 |
Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis.
Topics: Aged; Antitubercular Agents; Antiviral Agents; Carbamates; Chemical and Drug Induced Liver Injury; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tuberculosis; Valine | 2019 |
Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Cohort Studies; Coinfection; Databases, Factual; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Taiwan; Tuberculosis; Young Adult | 2014 |
Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report
Topics: Adult; Antiviral Agents; Ascitic Fluid; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Mycobacterium tuberculosis; Pleural Effusion; Postoperative Complications; Ribavirin; Safety; Treatment Outcome; Tuberculosis | 2008 |